FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Novartis Gains Breakthrough Designation for Breast Cancer Drug

[ Price : $8.95]

FDA grants Novartis a breakthrough therapy designation for LEE011 (ribociclib) and its use in combination with letrozole for treat...

Par Wants Adrenalin ANDA Limits

[ Price : $8.95]

Par Sterile Products asks FDA not to approve any generic form of its Adrenalin that does not contain the same inactive ingredients...

Consulting Editor John Scharmann Dead at 84

[ Price : $8.95]

Former FDA Webview consulting editor and longtime FDA stalwart John H. Scharmann dies at the age of 84, after a lengthy, valiant b...

Add Clinical Data to Biosimilar Labeling: Comments

[ Price : $8.95]

Four stakeholders recommend changes to a draft biosimilar labeling guidance to include clinical data.

Bayer Wins Essure Case That Cited FDA Form 483

[ Price : $8.95]

Bayer wins a court victory in a product liability case that cited an FDA-483 about its besieged Essure contraceptive device.

CGMP Violations Found at Xiamen Origin Biotech

[ Price : $8.95]

FDA warns Chinas Xiamen Origin Biotech about CGMP violations in manufacturing APIs.

QS Violations Cited in TriMed Inspection

[ Price : $8.95]

FDAs Los Angeles District Office warns TriMed about Quality System violations in its manufacturing of implantable bone fixation sy...

IEC Standards Conformance Guidance Out

[ Price : $8.95]

FDA publishes a draft guidance to harmonize agency and IEC performance standards for medical x-ray imaging equipment.

Clinical Investigators Most Warned for Not Following Plan

[ Price : $8.95]

Imarch Research says that all five FDA Warning Letters issued to clinical investigators in 2015 cited failing to ensure that the i...

FDA Denies Jame Fine Reconsideration Petition

[ Price : $8.95]

FDA denies a Jame Fine Chemicals petition seeking reconsideration of an agency decision that determined that an API it manufacture...